Holdings
Acuta Capital Partners, LLC
As of Sep 30, 2026, Acuta Capital Partners, LLC reported 32 positions worth US$125M. Largest: Praxis Precision Medicines, Inc., Whitehawk Therapeutics, Inc. and Tango Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Praxis Precision Medicines, Inc. | 84,193 | US$24.5M | +1,397 | Sep 30, 2026 |
| Whitehawk Therapeutics, Inc. | 4.69M | US$17.6M | no change | Sep 30, 2026 |
| Tango Therapeutics, Inc. | 410K | US$10.2M | +18,580 | Sep 30, 2026 |
| 4D Molecular Therapeutics, Inc. | 535K | US$7.66M | +27,308 | Sep 30, 2026 |
| argenx SE | 5,558 | US$5.33M | +853 | Sep 30, 2026 |
| ArriVent BioPharma, Inc. | 171K | US$5.17M | −47,801 | Sep 30, 2026 |
| Surrozen, Inc. | 153K | US$4.91M | −20,854 | Sep 30, 2026 |
| Vogenx Inc | 213K | US$4.86M | new | Sep 30, 2026 |
| Bright Minds Biosciences Inc. | 93,152 | US$4.64M | +407 | Sep 30, 2026 |
| Ocular Therapeutix, Inc. | 575K | US$4.41M | +42,062 | Sep 30, 2026 |